Time-kill kinetics of Streptococcus pneumoniae with reduced susceptibility to telithromycin

Chemotherapy

Volumn 53, Issue 3, 2007, Pages 190-193

  Al Lahham, Adnan ^a   Reinert, Ralf René ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Streptococcus pneumoniae; Telithromycin; Time kill kinetics

Indexed keywords

LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; TELITHROMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE LOCUS; GENE SEQUENCE; GENOTYPE; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GENOTYPE; KETOLIDES; KINETICS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; STREPTOCOCCUS PNEUMONIAE;

EID: 34147198469     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100517     Document Type: Article

References (15)

1. van Rensburg DJ, Fogarty C, Kohno S, Dunbar L, Rangaraju M, Nusrat R: Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin. Chemotherapy 2005;51:186-192.
2. Reinert RR: Clinical efficacy of ketolides in the treatment of respiratory tract infections. J Antimicrob Chemother 2004;53:918-927.
3. Reinert RR, Reinert S, van der Linden M, Cil MY, Al-Lahham A, Appelbaum P: Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 2005;49:2903-2913.
4. Reinert RR, Rodloff AC, Halle E, Baer W, Beyreiss B, Seifert H, Wichelhaus TA, Maass M, Mehl M: Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the ketolide telithromycin: results from the PROTEKT surveillance study (1999-2000). Chemotherapy 2004;50:143-151.
5. Reinert RR, Lütticken R, Reinert S, Al-Lahham A, Lemmen S: Antimicrobial resistance of Streptococcus pneumoniae isolates of out-patients in Germany, 1999-2000. Chemotherapy 2004;50:184-189.
6. Hisanaga T, Hoban DJ, Zhanel GG: Mechanisms of resistance to telithromycin in Streptococcus pneumoniae. J Antimicrob Chemother 2005;56:447-450.
7. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically (M7-A4). Approved Standard M100-S8, ed 4. Wayne, National Committee for Clinical Laboratory Standards, 2004.
8. Pankuch GA, Jacobs MR, Appelbaum PC: MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristindalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 1996;40:2071-2074.
9. Reinert RR, Franken C, van der Linden M, Lütticken R, Cil M, Al-Lahham A: Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003. Int J Antimicrob Agents 2004;24:43-47.
10. Montanari MP, Mingoia M, Giovanetti E, Varaldo PE: Differentiation of resistance phenotypes among erythromycin-resistant pneumococci. J Clin Microbiol 2001;39:1311-1315.
11. Enright MC, Spratt BG: A multilocus sequence typing scheme for Streptococcus pneumoniae identification of clones associated with serious invasive disease. Microbiology 1998;144:3049-3060.
12. Kadota J, Ishimatsu Y, Iwashita T, Matsubara Y, Tomono K, Tateno M, Ishihara R, Muller-Serieys C, Kohno S: Intrapulmonary pharmacokinetics of telithromycin, a new ketolide, in healthy Japanese volunteers. Antimicrob Agents Chemother 2002;46:917-921.
13. Farrell DJ, Felmingham D: Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003. Antimicrob Agents Chemother 2004;48:1882-1884.
14. Reinert RR, van der Linden M, Al-Lahham A: Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany. Antimicrob Agents Chemother 2005;49:3520-3522.
15. Reinert RR Al-Lahham A: Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22. Antimicrob Agents Chemother 2005;49:3011-3013.